SCHEMBL14166103

SCHEMBL14166103

NC(c1ccccc1)c1ccc(OC(=O)[C@H](O)c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
MAPK1 P28482 1/20 0.46
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
ELANE P08246 1/20 0.41
HPGD P15428 1/20 0.39
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SRD5A2 P31213 1/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CHRM2 P08172 2/20 0.38
CHRM1 P11229 2/20 0.38
CYP1A2 P05177 1/20 0.38
PKM P14618 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14166147 0.86 L3MBTL1 (0.42) LMNAMAPK1ATML3MBTL1CES2
SCHEMBL14166148 0.86 L3MBTL1 (0.42) LMNAMAPK1ATML3MBTL1CES2
SCHEMBL11119110 0.86 ATM (0.58) LMNAMAPK1ATML3MBTL1CES2
SCHEMBL2246434 0.86 ATM (0.58) LMNAMAPK1ATML3MBTL1CES2
SCHEMBL5690338 0.86 ATM (0.58) LMNAMAPK1ATML3MBTL1CES2
SCHEMBL8715340 0.83 LMNA (0.48) LMNAMAPK1ATML3MBTL1CES2
SCHEMBL8715341 0.83 LMNA (0.48) LMNAMAPK1ATML3MBTL1CES2
SCHEMBL27652140 0.78 MAPT (0.58) LMNAMAPK1ATML3MBTL1ELANE
SCHEMBL14166102 0.78 LMNA (0.43) LMNAMAPK1ATML3MBTL1CES2
SCHEMBL20943611 0.76 MGLL (0.54) CES2CES1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718280-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Chiesi Farmaceutici S.p.A. (IT) 2014-04-16 EP disclosed
WO-2012168359-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2012-12-13 WO disclosed